Hanmi to withdraw lawsuit against KFDA on Slimmer capsule.

Published: 2006-09-05 06:59:00

Updated: 2006-09-05 06:59:00

Hanmi earlier applied the health registration of Reductil generic drug called Slimmer capsule, which was a modified salt of sibutramine, a therapy for the treatment of obesity but the KFDA rejected it. Then, Hanmi raised an administrative lawsuit against the KFDA but now filed its withdrawal to t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK